Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingWages, Salaries and Other
Ratios

Ptc Therapeutics (PTCT) Leases (2019 - 2025)

Historic Leases for Ptc Therapeutics (PTCT) over the last 7 years, with Q3 2025 value amounting to $80.7 million.

  • Ptc Therapeutics' Leases rose 3567.98% to $80.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.7 million, marking a year-over-year increase of 3567.98%. This contributed to the annual value of $56.7 million for FY2024, which is 3831.61% down from last year.
  • Ptc Therapeutics' Leases amounted to $80.7 million in Q3 2025, which was up 3567.98% from $56.2 million recorded in Q2 2025.
  • Ptc Therapeutics' Leases' 5-year high stood at $141.6 million during Q2 2022, with a 5-year trough of $56.2 million in Q2 2025.
  • Moreover, its 5-year median value for Leases was $80.7 million (2021), whereas its average is $83.4 million.
  • Per our database at Business Quant, Ptc Therapeutics' Leases skyrocketed by 17377.1% in 2021 and then tumbled by 4090.66% in 2024.
  • Ptc Therapeutics' Leases (Quarter) stood at $77.4 million in 2021, then soared by 32.3% to $102.4 million in 2022, then decreased by 10.28% to $91.9 million in 2023, then crashed by 38.32% to $56.7 million in 2024, then soared by 42.33% to $80.7 million in 2025.
  • Its Leases was $80.7 million in Q3 2025, compared to $56.2 million in Q2 2025 and $57.3 million in Q1 2025.